News-Detailansicht

freigestelltes Porträtbild für Kontakte auf der Website
Prof. Dr. Tor Henrik Semb

Director, Institute of Translational Stem Cell Research (ITS), Lund University Diabetes Centre Department of Clinical Sciences Clinical Research Centre Malmö, Sweden

View profile
Semb Lab Behind the Scenes

Diabetes, ITS, IDR,

Handcrafted Langerhans Islets: New Hope for Type 1 Diabetes Patients?

Our organs do a remarkable job day in and day out, without ourselves even having to think about it. Our body has its own ventilation system, a clearance system for toxins, and a system to balance energy homeostasis. But what if one of these systems…

6 well plate - cellcuture with medium

Awards & Grants, Diabetes, TDI, IDOT, IDR,

Advancing Stem Cell-Based Therapy for Type 1 Diabetes

Helmholtz Munich researchers receive 2.25 Mio US Dollar JDRF Grant 

With a 2.25 million US dollar grant provided by the Juvenile Diabetes Research Foundation (JDRF), Prof. Matthias Hebrok, Prof. Heiko Lickert, and Prof. Carolin Daniel from the…

Awards & Grants, ITS,

EU-Project ISLET: Helmholtz Munich takes over coordination

The EU-funded ISLET project brings together leading experts in the field of stem cell research to discover a new advanced cell therapy in type 1 diabetes. The aim is to free patients from the daily use of an insulin pump by replacing the damaged…